To view this email as a web page, click here.
August 13, 2019
 
LHON gene therapy: Deciphering phase III data
image description here Phase III studies of a gene therapy for Leber hereditary optic neuropathy have generated some unexpected positive findings. There is biologic plausibility to explain the data, according to Robert C. Sergott, MD.

Continue
 
Flying solo poses challenges, flexibility and support vital
image description here Ophthalmologists operating a small practice are looking for better patient relationships and independence, according to Lisa M. Nijm, MD, JD.

Learn more
 
Ophthalmology grabs Wall Street’s attention
image description here Josh Mali, MD, shares how AbbVie’s recent financial takeover rattles up the ophthalmic space, and what this means for future pharmaceutical acquisitions.

Find out
 
ADVERTISEMENT
Voting now open!
Ophthalmology Times 2019 Resident Writers Award Program entries are here for your review and vote. Join us rewarding excellence in education! Learn more.
 
RELATED ARTICLES
 
Set expectations for glaucoma patients undergoing cataract surgery
(VIDEO) OSPREY trial aids fluid assessment
Photoreceptor replacement cells enter therapeutic space
Treating chalazion with IPL therapy
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.